A blueprint for building a patient-centric pharma companyWhile the industry appears united in its commitment to patient centricity, the practicalities of embedding the ethos into Share XA blueprint for building a patient-centric pharma companyhttps://pharmaphorum.com/views-analysis-patients/whitepaper-provides-a-blueprint-to-building-a-patient-centricity-company/
Launch excellence in a disrupted worldThe accelerating speed of change within the pharmaceutical launch environment raises considerable challenges for launch excellence, as companies Share XLaunch excellence in a disrupted worldhttps://pharmaphorum.com/views-analysis-sales-marketing/launch-excellence-in-a-disrupted-world/
Geopolitical uncertainty grips digital health investorsGalen Growth Asia has released its Q3 2019 Asia Pac HealthTech, aka digital health, ecosystem key trends interim Share XGeopolitical uncertainty grips digital health investorshttps://pharmaphorum.com/views-analysis-digital/geopolitical-uncertainty-grips-digital-health-investors/
Secret US-UK talks on drug pricing revealedDespite the UK still not leaving the European Union – pencilled in for the 31 January 2020 at Share XSecret US-UK talks on drug pricing revealedhttps://pharmaphorum.com/views-analysis-market-access/secret-us-uk-talks-on-drug-pricing-revealed/
Harnessing the potential of AI in commercial life sciencesArtificial intelligence (AI) has gained significant momentum in life sciences over the past few years. With the promise Share XHarnessing the potential of AI in commercial life scienceshttps://deep-dive.pharmaphorum.com/magazine/digital-health/harnessing-the-potential-of-ai-in-commercial-life-sciences/
How augmented reality is leading to real world patient improvementsIt’s been a long time since the summer of 2016 when Pokémon Go was the biggest news in Share XHow augmented reality is leading to real world patient improvementshttps://pharmaphorum.com/views-analysis-digital/how-augmented-reality-is-leading-to-real-world-patient-improvements/
FCS: A life-limiting conditionGP Karishma Patel tells us about the daily challenges of living with the ultra-rare condition Familial Chylomicronaemia Syndrome Share XFCS: A life-limiting conditionhttps://pharmaphorum.com/views-analysis-patients/fcs-a-life-limiting-condition/
Q&A: Draper’s Jenna Balestrini on the future of CAR-TAs exciting as CAR-T is, there are still myriad challenges preventing it from reaching its full potential. Jenna Share XQ&A: Draper’s Jenna Balestrini on the future of CAR-Thttps://pharmaphorum.com/views-analysis-oncology/qa-drapers-jenna-balestrini-on-the-future-of-car-t/
Measuring value to ensure access in divisive timesGlobally, balancing rising healthcare costs with the drive for innovation is a political hot potato – is a Share XMeasuring value to ensure access in divisive timeshttps://pharmaphorum.com/views-analysis-market-access/measuring-value-to-ensure-access-in-divisive-times/
